92 related articles for article (PubMed ID: 1355467)
21. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
22. Management of nausea and vomiting caused by anticancer drugs: state of the art.
Pisters KM; Kris MG
Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
[TBL] [Abstract][Full Text] [Related]
23. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
24. [A new antiemetic ramosetron hydrochloride].
Tsukagoshi S
Gan To Kagaku Ryoho; 1997 Feb; 24(3):371-80. PubMed ID: 9051143
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
26. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
27. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
Constenla M
Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
[TBL] [Abstract][Full Text] [Related]
28. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of drug-induced nausea and vomiting].
Herrstedt J; Dombernowsky P
Ugeskr Laeger; 1994 Jan; 156(4):453-60. PubMed ID: 8140660
[TBL] [Abstract][Full Text] [Related]
30. Comparative activity of antiemetic drugs.
Jordan K; Schmoll HJ; Aapro MS
Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
[TBL] [Abstract][Full Text] [Related]
31. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
Hainsworth JD
Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
[TBL] [Abstract][Full Text] [Related]
32. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
33. Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs.
Bountra C; Gale JD; Gardner CJ; Jordan CC; Kilpatrick GJ; Twissell DJ; Ward P
Oncology; 1996 Jun; 53 Suppl 1():102-9. PubMed ID: 8692545
[TBL] [Abstract][Full Text] [Related]
34. The ups and downs of novel antiemetic drugs, part 2: an illustration.
Stahl SM
J Clin Psychiatry; 2003 Jun; 64(6):626-7. PubMed ID: 12823074
[TBL] [Abstract][Full Text] [Related]
35. The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting.
Leslie RA; Shah Y; Thejomayen M; Murphy KM; Robertson HA
Can J Physiol Pharmacol; 1990 Feb; 68(2):279-88. PubMed ID: 2311005
[TBL] [Abstract][Full Text] [Related]
36. A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron.
Cox EH; Veyrat-Follet C; Beal SL; Fuseau E; Kenkare S; Sheiner LB
J Pharmacokinet Biopharm; 1999 Dec; 27(6):625-44. PubMed ID: 11153449
[TBL] [Abstract][Full Text] [Related]
37. Emerging differences between 5-HT3 receptor antagonists.
Marr HE; Davey PT; Bartlett AJ
Anticancer Drugs; 1991 Dec; 2(6):513-8. PubMed ID: 1806029
[TBL] [Abstract][Full Text] [Related]
38. [Hyperprolactinaemia antiemetic-induced; comparison between four drugs (author's transl)].
Segrestaa JM; Gueris J; Julien D; Tiar M
Therapie; 1979; 34(4):437-43. PubMed ID: 531776
[No Abstract] [Full Text] [Related]
39. A method for the clinical evaluation of antiemetic agents.
BELLVILLE JW; BROSS ID; HOWLAND WS
Anesthesiology; 1959; 20():753-60. PubMed ID: 13798617
[No Abstract] [Full Text] [Related]
40. A comparative study of eleven anti-emetic drugs in dogs.
WYANT GM
Can Anaesth Soc J; 1962 Sep; 9():399-407. PubMed ID: 14008596
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
